Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...

Eli Lilly (LLY.N), opens new tab, the $815 billion maker of blockbuster weight-loss drugs Mounjaro and Zepbound, is trading at more than double the valuation multiple of Wegovy maker Novo Nordisk ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

"The highest dose of tirzepatide is five times higher than the approved maximum doses of semaglutide," said Novo Nordisk adding that in the trial, the among of weight loss for Wegovy was lower ...

Ozempic is primarily a diabetes drug, whereas Wegovy is a weight loss drug with a higher dose of semaglutide than Ozempic. Confusing? You betcha. Here’s a quick summary to help. It’s FDA ...